NOVAVAX INC (NVAX) — Revenue

Annual figures by fiscal year, from SEC filings.

2010: $343.0K2011: $14.69M2012: $22.08M2013: $20.91M2014: $30.66M2015: $36.25M2016: $15.35M2017: $31.18M2018: $34.29M2019: $18.66M2020: $475.60M2021: $1.15B2022: $1.98B2023: $983.71M2024: $682.16M2025: $1.12B$1.12B
2010Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$1.12B+64.7%
2024$682.16M-30.7%
2023$983.71M-50.4%
2022$1.98B+72.9%
2021$1.15B+141.0%
2020$475.60M+2448.5%
2019$18.66M-45.6%
2018$34.29M+10.0%
2017$31.18M+103.1%
2016$15.35M-57.6%
2015$36.25M+18.2%
2014$30.66M+46.6%
2013$20.91M-5.3%
2012$22.08M+50.3%
2011$14.69M+4182.2%
2010$343.0K